[Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
作者信息
Chiche P, Bénaim R, Samama M, Maury J
出版信息
Coeur Med Interne. 1978 Jan-Mar;17(1):59-66.
PMID:639489
Abstract
摘要
相似文献
1
[Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
Coeur Med Interne. 1978 Jan-Mar;17(1):59-66.
2
Thrombolytic therapy of pulmonary thromboembolism.
Prog Cardiovasc Dis. 1979 Mar-Apr;21(5):333-41. doi: 10.1016/0033-0620(79)90006-9.
3
[When is fibrinolytic therapy indicated?].
Med Klin. 1980 Feb 1;75(3):98-107.
4
[Letter: Thrombolytic treatment in subacute and chronic pulmonary arterial thrombosis].
Nouv Presse Med. 1976 May 29;5(22):1428-9.
5
Thrombolytic therapy for pulmonary emboli.
Drug Ther Bull. 1980 Jun 6;18(12):45-7.
6
Current concepts: guidelines for the use of thrombolytic agents.
N Engl J Med. 1979 Dec 6;301(23):1266-70. doi: 10.1056/NEJM197912063012305.
7
Thrombolytic therapy: Current status.
N Engl J Med. 1975 Nov 20;293(21):1073-8. doi: 10.1056/NEJM197511202932106.
8
Urokinase & streptokinase in pulmonary embolism.
Compr Ther. 1976 Aug;2(8):18-22.
9
Thrombolytic therapy: differences between streptokinase and urokinase.
Vasc Surg. 1977 Nov-Dec;11(6):378-83. doi: 10.1177/153857447701100607.
10
Thrombolytic therapy in pulmonary embolism.
Vasc Surg. 1977 Nov-Dec;11(6):349-58. doi: 10.1177/153857447701100603.
引用本文的文献
1
Optimal management of thymic malignancies: current perspectives.
Cancer Manag Res. 2019 Jul 22;11:6803-6814. doi: 10.2147/CMAR.S171683. eCollection 2019.
Zotero 插件